Suprazygomatic Block in Cleft Palate Surgery in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 14, 2018

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Cleft Palate
Interventions
DRUG

Bupivacaine

"The study drugs will be prepared by an anesthesiologist not involved in performing the block, patient care or in data collection. Patients will be randomly allocated into two groups of 40 patients each:~Group A: will receive 0.2 ml/kg/side of bupivacaine (0.125%)."

DRUG

Dexmedetomidine

Group B: will receive 0.2 ml/kg/side of bupivacaine (0.125%) + 0.5 µ/kg of dexmedetomidine.

DRUG

paracetamol

paracetamol

Trial Locations (1)

Unknown

Assiut University Hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03412474 - Suprazygomatic Block in Cleft Palate Surgery in Children | Biotech Hunter | Biotech Hunter